Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron and Gen-Probe blood-screening:

This article was originally published in Clinica

Executive Summary

Chiron and Gen-Probe have gained the go-ahead to sell a fully automated blood screening system in Europe. Under a partnership between both firms, the Procleix Ultrio assay for simultaneously detecting HIV-1 and the hepatitis B and C viruses in specimens from donated blood, plasma, organs and tissue can now be marketed for use on the high-throughput Procleix Tigris system. Gen-Probe says that it expects the European launch of the system and assay to be an important growth driver for the San Diego, California-based company in 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060558

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel